However, we see no reason to assume that the activation of apoptosis and CSEN pathways triggered by O6MeG adducts does not also take place in GBM cells embedded in a complex tissue structure in vivo, since these reflect basic molecular processes. The gene discussed is KCNIP3; the disease is glioblastoma.